Skip to main content
SKIN ELEMENTS LIMITED logo

SKIN ELEMENTS LIMITED — Investor Relations & Filings

Ticker · SKN ISIN · AU000000SKN7 ASX Manufacturing
Open in API
Filings indexed 561 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country AU Australia
Listing ASX SKN

About SKIN ELEMENTS LIMITED

https://skinelementslimited.com

Skin Elements Limited focuses on the research, development, and commercialization of natural skincare and antimicrobial technologies. The company specializes in formulating products using plant-based ingredients and proprietary delivery systems designed to provide high-performance alternatives to traditional synthetic chemicals. Key product lines include SoLeo Organics, a range of natural sunscreens; PapayaActivs, which offers therapeutic skincare solutions derived from pawpaw extract; and Invisi Shield, an alcohol-free antimicrobial technology. The company’s core activities involve the integration of organic components with advanced dermatological science to address skin protection, healing, and hygiene. Skin Elements prioritizes sustainable, non-toxic formulations for global consumer markets, emphasizing safety and efficacy in personal care and environmental protection applications.

Recent filings

Filing Released Lang Actions
ECO-Nurture Commercialisation Update 3 pages 692.2KB
Regulatory Filings Classification · 62% confidence The document is an ASX announcement providing a commercialisation update—detailing progress on product testing, negotiations for distribution agreements, and potential upfront payments. It does not contain financial statements, earnings metrics, board changes, dividends, share issuances, or proxy materials. It is not certifying or attaching a formal financial report, nor is it an investor presentation or management discussion of results. As it is primarily a general business update filed on the exchange and does not fit any more specific category, it defaults to a generic regulatory announcement.
2026-05-14 English
Notice of Extraordinary General Meeting/Proxy Form 32 pages 3.8MB
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a formal notice of an Extraordinary General Meeting of shareholders, including the explanatory notes, resolutions to be considered, and instructions on how to vote or lodge proxies. It is materials sent to shareholders to provide information and solicit votes for the meeting, which fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-05-13 English
Clarification Regarding Off-Market Transfer of Shares 2 pages 164.9KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Skin Elements Limited clarifying an off-market transfer of shares between entities holding shares for the same beneficial owner (the Giglia Family). It discusses share registry updates, beneficial ownership, and compliance with ASX Listing Rules. There is no financial data, no report attached or referenced as being published, and no mention of earnings, management changes, or other report types. The document is a regulatory announcement clarifying shareholding and compliance matters, fitting best under Regulatory Filings (RNS). The document length is 4345 characters, which is relatively short and consistent with an announcement rather than a full report.
2026-05-07 English
Amendment to Appendix 3Y - Peter Malone 5 pages 330.4KB
Director's Dealing Classification · 100% confidence The document is an ASX announcement titled 'Amendment to Appendix 3Y Peter Malone' which is a Change of Director's Interest Notice. It details corrections to a previously lodged Appendix 3Y regarding the director's securities holdings and transactions. Appendix 3Y is a standard form used in Australian stock exchange filings to disclose changes in directors' interests in securities. The document includes detailed information about the director's shareholdings, options, and transactions, consistent with a Director's Dealing report. There is no indication of financial results, management discussion, or other report types. The document is not a report publication announcement or a certification but a direct disclosure of insider transactions. Therefore, the correct classification is Director's Dealing (DIRS).
2026-05-06 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 664.6KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Activity Report - Period ending 31 March 2026' and contains detailed operational updates, product development progress, commercialisation plans, and a summary of operating cash flows for the quarter. It includes financial data such as receipts from customers, payments for R&D, manufacturing, marketing, staff costs, and net cash outflows from operating activities. The presence of an Appendix 4C cash flow report, which is a standard quarterly cash flow report for entities subject to ASX Listing Rule 4.7B, confirms this is a quarterly financial report. The document is approximately 15,000 characters long, indicating it is a substantive report rather than a brief announcement. There is no indication that this is an annual report, earnings release, or other specific filing type. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-04-29 English
Initial Director's Interest Notice x 3 6 pages 222.3KB
Director's Dealing Classification · 95% confidence The document is an ASX Appendix 3X “Initial Director’s Interest Notice” under Listing Rule 3.19A.1, disclosing directors’ relevant interests in securities. This clearly falls under the ‘Director’s Dealing’ category, as it reports personal share holdings of newly appointed directors (insider transactions/disclosures).
2026-04-26 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.